<DOC>
	<DOCNO>NCT00175357</DOCNO>
	<brief_summary>The objective study determine whether closely supervise provision injectable , pharmaceutical-grade heroin ( combination oral methadone ) effective methadone therapy alone recruiting , retain , benefit long-term heroin user help current standard treatment option .</brief_summary>
	<brief_title>NAOMI : A Study Compare Medically-prescribed Heroin With Oral Methadone Chronic Opiate Addiction</brief_title>
	<detailed_description>This two-centre ( Vancouver , Montreal ) RCT involve total 235 volunteer . Eligible participant randomize injectable heroin combine oral methadone desire ( 45 % ) versus oral methadone alone ( 45 % ) . A subset 10 % randomize injectable hydromorphone ( Dilaudidâ„¢ ) . Hydromorphone heroin give double-blind fashion ; purpose permit validation report illicit use heroin urine test hydromorphone group . Research visit conduct quarterly occur independently treatment clinic visit . Incentives use maintain research follow-up whether subject retain treatment . The analysis intent-to-treat . The primary outcome interest 1 ) recruitment retention study 2 ) illicit drug use criminal behavior ( determined Europ-ASI ) 12 month . Secondary outcome measure social function ( e.g. , social integration functioning , quality life ) cost-benefit/effectiveness intervention .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>1 . Opioid Dependence confirm DSMIV diagnostic criterion 2 . 25 year age old 3 . 5 year opioid use 4 . Regular opioid injection use past month least 8 month past 12 month ( self report ; regular use define injecting opioids least 4 day week ) ; 50 % injection prior year must involve heroin ) . 5 . Minimum oneyear residence site/city location 6 . No enrollment opioid substitution ( e.g . methadone ) program within prior 6 month enrollment define receive least 45 milligram prescribe methadone per day 30 consecutive day prior 6 month 7 . At least two previous episode opiate addiction treatment ( methadone maintenance , detoxification , residential care , etc ) , least one occasion , patient receive least 60 mg methadone daily least 30 day 40 day period 8 . Willingness ability adhere study protocol followup schedule determine threeweek prerandomization period ( see Section C.4 ) 9 . Documentation fulfillment study criterion ( prison record , treatment record , cohort study enrollment , urine sampling ) 10 . Provide write informed consent . 1 . Diagnosis severe medical psychiatric condition contraindicate heroin treatment 2 . Pregnancy upon study entry 3 . On parole current justice system involvement likely result extend period incarceration ( 4 month ) study period ( e.g . schedule trial indictable offense , jail , etc ) 4 . Hydromorphone class C teratogen give pregnant woman . All female subject upon study entry urge engage protect sexual intercourse provide consent undergo monthly pregnancy test course study . 5 . Serum bilirubin &gt; 2.5 x normal 6 . Stage II great hepatic encephalopathy 7 . Chronic respiratory disease result rest respiratory rate &gt; 20/minute 8 . Bipolar Mood Disorder , Schizophrenia psychotic disorder active psychotic symptom within past 6 month 9 . Major Depression refractory medical management require electroconvulsive therapy within past 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Opiate addiction</keyword>
	<keyword>medical heroin</keyword>
	<keyword>methadoneRCT</keyword>
</DOC>